Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2002 Oct;93(10):1123–1128. doi: 10.1111/j.1349-7006.2002.tb01214.x

Clinical Significance of Glucose Transporter 1 (GLUT1) Expression in Human Breast Carcinoma

Sung Soo Kang 1, Yi Kyeong Chun 2, Min Hee Hur 1, Hae Kyung Lee 1, Yee Jeong Kim 2, Sung Ran Hong 2, Jee Hyun Lee 1, Sung Gong Lee 1, Yong Koo Park 3,✉
PMCID: PMC5926879  PMID: 12417042

Abstract

Glucose uptake and glycolytic metabolism are enhanced in cancer cells compared to normal cells and tissues. Increased expression of glucose transporter 1 (GLUT1) has been reported in human malignant cells. The aim of this study is to determine the expression of the facilitative glucose transporter protein GLUT1 in human breast carcinomas and a possible correlation between GLUT1 expression and clinical outcome including disease‐free or overall survival. One hundred consecutive formalin‐fixed, paraffin‐embedded sections of invasive breast carcinomas were evaluated by means of immunohistochemical staining of GLUT1. Forty‐seven (47%) of 100 breast carcinomas showed positive staining for GLUT1. Expression of GLUT1 correlated significantly with nuclear grade (P<0.001), estrogen receptor status (P=0.002), and progesterone receptor status (P=0.001). The mean disease‐free survival periods of GLUTl‐positive and ‐negative patients were 47±2.4 months and 54.3±1.3 months, respectively (P=0.017). The mean overall survival periods of GLUTl‐positive and ‐negative patients were 48.7±2.2 and 56.1±1.3 months, respectively (P=0.043). In the multivariate analysis, disease‐free survival correlated significantly with GLUT1, tumor size, and lymph node involvement (P=0.043, P=0.014, and P=0.045, respectively). In analysis of overall survival, however, lymph node involvement, tumor size, and nuclear grade were statistically significant (P=0.024, P=0.023, and P=0.003, respectively). Our data suggest that absence of GLUT1 expression significantly increases disease‐free survival. These findings demonstrate that GLUT1 expression in breast carcinoma can be a marker of aggressive biological behavior and identifies a worse prognosis in breast carcinoma patients.

Keywords: Breast carcinoma, GLUT1, Immunohistochemistry, Prognosis

Full Text

The Full Text of this article is available as a PDF (804.7 KB).

REFERENCES

  • 1. ) Warberg , O.On the origin of cancer cells . Science , 123 , 306 – 314 ( 1956. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Smith , T. A. D.Facilitative glucose transporter expression in human cancer tissue . Br. J. Biomed. Sci. , 56 , 285 – 292 ( 1999. ). [PubMed] [Google Scholar]
  • 3. ) Zamora‐Leon , S. , Golde , D. , Concha II , Rivas , C. , Delgado‐Lopez , F. , Baselga , J. , Nualart , F. and Vera , J.Expression of the fructose transporter GLUTS in human breast cancer . Proc. Natl. Acad. Sci. USA , 93 , 1847 – 1852 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Grover‐McKay , M. , Walsh , S. , Seftor , E. , Thomas , P. and Hendrix , M.Role of glucose transporter 1 in human breast cancer . Pathol. Oncol. Res. , 4 , ( 2 ), 115 – 120 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Younes , M. , Lechago , L. and Lechago , J.Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases . Clin. Cancer Res. , 2 , 1151 – 1154 ( 1996. ). [PubMed] [Google Scholar]
  • 6. ) Haber , R. , Rathan , A. , Weiser , K. , Pritsker , A. , Itzkowitz , S. , Bodian , C. , Slater , G. , Weiss , A. and Burstein , D.GLUT1 glucose transporter expression in colorectal carcinoma; a marker for poor prognosis . Cancer , 83 , 34 – 40 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Sakashita , M. , Aoyama , N. , Minami , R. , Maekawa , S. , Kuroda , K. , Shirasaka , D. , Ichihara , T. , Kuroda , Y. , Maeda , S. and Kasuga , M.GLUT1 expression in Tl and T2 stage colorectal carcinomas; its relationship to clinicopathological features . Eur. J. Cancer , 37 , 204 – 209 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Furudoi , A. , Tanaka , S. , Haruma , K. , Yoshihara , M. , Sumii , K. , Kajiyama , G. and Shimamoto , F.Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma . Oncology , 60 , 162 – 169 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Haber , R. , Weiser , K. , Pritsker , A. , Reder , I. and Burstein , D.GLUT1 glucose transporter expression in benign and malignant thyroid nodules . Thyroid , 7 , 363 – 367 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Younes , M. , Brown , R. , Stephenson , M. , Gondo , M. and Cagle , P.Overexpression of GLUT1 and GLUT3 in stage 1 non‐small cell lung carcinoma is associated with poor survival . Cancer , 80 , 1046 – 1051 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Ito , T. , Noguchi , Y. , Satoh , S. , Hayashi , H. , Inayama , Y. and Kitamura , H.Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage . Mod. Pathol. , 11 , 437 – 443 ( 1998. ). [PubMed] [Google Scholar]
  • 12. ) Noguchi , Y. , Marat , D. , Yoshigawa , T. , Doi , C. , Fukuzawa , K. , Tsuburaya , A. , Satoh , S. and Ito , T.Expression of facilitative glucose transporters in gastric tumors . Hepatogastroenterology , 46 , 2683 – 2689 ( 1999. ). [PubMed] [Google Scholar]
  • 13. ) Reisser , C. , Eichhorn , K. , Herold‐Mende , C. , Born , A. and Bannasch , P.Expression of facilitative glucose transporter proteins during development of squamous cell carcinoma of the head and neck . Int. J. Cancer , 80 , 194 – 198 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Chang , S. , Lee , S. , Lee , C. , Kim , J. and Kim , Y.Expression of human erythrocyte glucose transporter in transitional cell carcinoma of the bladder . Urology , 55 , 448 – 452 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Younes , M. , Juarez , D. , Lechago , L. and Lerner , S.GLUT1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival . Anticancer Res. , 21 , 575 – 578 ( 2001. ). [PubMed] [Google Scholar]
  • 16. ) Nagase , Y. , Takata , K. , Moriyama , N. , Aso , Y. , Murakami , T. and Hirano , H.Immunohistochemical localization of glucose transporters in human renal cell carcinoma . J. Urol. , 153 , 798 – 801 ( 1995. ). [PubMed] [Google Scholar]
  • 17. ) Wang , B. , Kalir , T. , Sabo , E. , Sherman , D. , Cohen , C. and Burstein , D.Immunohistochemical staining of GLUT1 in benign hyperplastic, and malignant endometrial endothelia . Cancer , 88 , 2774 – 2781 ( 2000. ). [PubMed] [Google Scholar]
  • 18. ) Fisher , E. , Gregorio , R. , Fisher , B. , Redmond , C. , Vellios , F. and Sommers , S.The pathology of National Surgical Adjuvant Breast Project (Protocol 4) . Cancer , 36 , 1 – 85 ( 1975. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Mueckler , M.Facilitative glucose transporters . Eur. J. Biochem. , 219 , 713 – 725 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Flier , J. , Mueckler , M. , Usher , P. and Lodish , H.Elevated levels of glucose transport and transporter messenger RNA are induced ras or src oncogenes . Science , 235 , 1492 – 1495 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Rollins , B. , Morrison , E. , Usher , P. and Flier , J.Platelet‐derived growth factor regulates glucose transporter expression . J. Biol. Chem. , 263 , 16523 – 16526 ( 1988. ). [PubMed] [Google Scholar]
  • 22. ) Merrall , N. , Plevin , R. and Gould , G.Growth factors, mitogens, oncogenes and the regulation of glucose transport . Cell. Signal. , 5 , 667 – 675 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Younes , M. , Brown , R. , Mody , D. , Fernandez , L. and Laucirica , R.GLUT1 expression in human breast carcinoma correlates with human prognostic markers . Anticancer Res. , 15 , 2895 – 2898 ( 1995. ). [PubMed] [Google Scholar]
  • 24. ) Brown , R. and Wahl , R.Overexpression of glut1 glucose transporter in human breast cancer. An immunochemical study . Cancer , 72 , 2979 – 2985 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Alo , P. , Botti , C. , Galati , G. , Sebastiani , V. , Andreano , T. , Di Tondo , U. and Pizer , E.Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue . Am. J. Clin. Pathol. , 116 , 129 – 134 ( 2001. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Binder , C. , Binder , L. , Schauer , A. and Hiddemann , W.Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues . Anti-cancer Res. , 17 , 4299 – 4304 ( 1997. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES